Back
Day Range
$238.82
$248.06
52-Week Range
$187.43
$322.34
Volume
649,326
50D / 200D Avg
$246.84
/
$252.44
Prev Close
$241.40
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 35.8 | 0.4 |
| P/B | 5.6 | 2.9 |
| ROE % | 16.9 | 3.7 |
| Net Margin % | 16.1 | 3.9 |
| Rev Growth 5Y % | 2.1 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$303.33
+23.7%
Low: $265.00
High: $340.00
Forward P/E
30.1
Forward EPS
$8.02
EPS Growth (est.)
+0.0%
Est. Revenue
3.2 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$11.36
$11.20 – $11.51
|
4 B | 1 |
| FY2029 |
$11.11
$10.95 – $11.26
|
3.9 B | 1 |
| FY2028 |
$10.14
$9.57 – $10.70
|
3.7 B | 2 |
Key Takeaways
Revenue grew 2.08% annually over 5 years — modest growth
ROE of 16.85% — decent returns on equity
Net margin of 16.06% shows strong profitability
Debt/Equity of 0.13 — conservative balance sheet
Generating 468.90M in free cash flow
P/E of 35.78 — premium valuation
Growth
Revenue Growth (5Y)
2.08%
Revenue (1Y)6.26%
Earnings (1Y)0.20%
FCF Growth (3Y)6.36%
Quality
Return on Equity
16.85%
ROIC12.89%
Net Margin16.06%
Op. Margin20.09%
Safety
Debt / Equity
0.13
Current Ratio3.02
Interest Coverage1029.00
Valuation
P/E Ratio
35.78
P/B Ratio5.56
EV/EBITDA28.00
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.26% | Revenue Growth (3Y) | 2.06% |
| Earnings Growth (1Y) | 0.20% | Earnings Growth (3Y) | -8.79% |
| Revenue Growth (5Y) | 2.08% | Earnings Growth (5Y) | -7.06% |
| Profitability | |||
| Revenue (TTM) | 3.07B | Net Income (TTM) | 493.70M |
| ROE | 16.85% | ROA | 11.56% |
| Gross Margin | 35.89% | Operating Margin | 20.09% |
| Net Margin | 16.06% | Free Cash Flow (TTM) | 468.90M |
| ROIC | 12.89% | FCF Growth (3Y) | 6.36% |
| Safety | |||
| Debt / Equity | 0.13 | Current Ratio | 3.02 |
| Interest Coverage | 1029.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 35.78 | P/B Ratio | 5.56 |
| P/S Ratio | 5.75 | PEG Ratio | 34.00 |
| EV/EBITDA | 28.00 | Dividend Yield | 0.00% |
| Market Cap | 17.66B | Enterprise Value | 17.29B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.07B | 2.89B | 2.95B | 2.89B | 2.83B |
| Net Income | 493.70M | 492.70M | 593.40M | 585.90M | 661.80M |
| EPS (Diluted) | 6.80 | 6.69 | 7.88 | 7.73 | 8.67 |
| Gross Profit | 1.10B | 1.00B | 1.13B | 1.14B | 1.17B |
| Operating Income | 617.40M | 594.60M | 710.90M | 763.50M | 758.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4.27B | 3.64B | 3.83B | 3.62B | 3.31B |
| Total Liabilities | 1.09B | 961.10M | 948.50M | 931.90M | 978.40M |
| Shareholders' Equity | 3.18B | 2.68B | 2.88B | 2.68B | 2.34B |
| Total Debt | 416.70M | 305.30M | 309.00M | 317.90M | 325.30M |
| Cash & Equivalents | 791.30M | 484.60M | 853.90M | 894.30M | 762.60M |
| Current Assets | 1.98B | 1.54B | 1.94B | 1.92B | 1.74B |
| Current Liabilities | 654.90M | 550.40M | 671.80M | 519.00M | 594.10M |